Disruption of TBP-2 ameliorates insulin sensitivity and secretion without affecting obesity

Nature Communications

Volumn 1, Issue 8, 2010, Pages

  Yoshihara, Eiji ^a   Fujimoto, Shimpei ^a   Inagaki, Nobuya ^a   Okawa, Katsuya ^b   Masaki, So ^a   Yodoi, Junji ^a   Masutani, Hiroshi ^a  

^a KYOTO UNIVERSITY   (Japan)

^b KYOWA HAKKO KOGYO CO LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; ADIPOCYTOKINE; INSULIN RECEPTOR SUBSTRATE 1; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; PROTEIN KINASE B; THIOREDOXIN INTERACTING PROTEIN; UNCOUPLING PROTEIN 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CALCIUM TRANSPORT; CONTROLLED STUDY; DOWN REGULATION; ENZYME SYNTHESIS; FEMALE; GLUCOSE INTOLERANCE; HYPERGLYCEMIA; INSULIN RELEASE; INSULIN SENSITIVITY; MALE; NONHUMAN; OBESITY; PROTEIN EXPRESSION; SKELETAL MUSCLE; UPREGULATION;

MUS;

EID: 78650064532     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms1127     Document Type: Article

References (50)

1. Biddinger, S. B. & Kahn, C. R. From mice to men: insights into the insulin resistance syndromes. Annu. Rev. Physiol. 68, 123-158 (2006).
2. Guilherme, A., Virbasius, J. V., Puri, V. & Czech, M. P. Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes. Nat. Rev. Mol. Cell Biol. 9, 367-377 (2008).
3. Pratley, R. E. & Weyer, C. The role of impaired early insulin secretion in the pathogenesis of Type II diabetes mellitus. Diabetologia 44, 929-945 (2001).
4. Anello, M. et al. Functional and morphological alterations of mitochondria in pancreatic beta cells from type 2 diabetic patients. Diabetologia 48, 282-289 (2005).
5. Maechler, P. & Wollheim, C. B. Mitochondrial function in normal and diabetic beta-cells. Nature 414, 807-812 (2001).
6. Bodnar, J. S. et al. Positional cloning of the combined hyperlipidemia gene Hyplip1. Nat. Genet. 30, 110-116 (2002).
7. Chen, K. S. & DeLuca, H. F. Isolation and characterization of a novel cDNA from HL-60 cells treated with 1,25-dihydroxyvitamin D-3. Biochim. Biophys. Acta. 1219, 26-32 (1994).
8. Nishiyama, A. et al. Identification of thioredoxin-binding protein-2/vitamin D(3) up-regulated protein 1 as a negative regulator of thioredoxin function and expression. J. Biol. Chem. 274, 21645-21650 (1999).
9. Nishinaka, Y. et al. Importin alpha1 (Rch1) mediates nuclear translocation of thioredoxin-binding protein-2/vitamin D(3)-up-regulated protein 1. J. Biol. Chem. 279, 37559-37565 (2004).
10. Oka, S. et al. Thioredoxin-binding protein-2-like inducible membrane protein is a novel vitamin D3 and peroxisome proliferator-activated receptor (PPAR)gamma ligand target protein that regulates PPARgamma signaling. Endocrinology 147, 733-743 (2006).
11. Patwari, P. et al. Thioredoxin-independent regulation of metabolism by the alpha-arrestin proteins. J. Biol. Chem. 284, 24996-5003 (2009).
12. Zhang, P. et al. The ubiquitin ligase itch regulates apoptosis by targeting thioredoxin-interacting protein for ubiquitin-dependent degradation. J. Biol. Chem. 285, 8869-79 (2010).
13. Zhou, R., Tardivel, A., Thorens, B., Choi, I. & Tschopp, J. Thioredoxin-interacting protein links oxidative stress to inflammasome activation. Nat. Immunol. 11, 136-140 (2010).
14. Nishinaka, Y. et al. Loss of thioredoxin-binding protein-2/vitamin D3 up-regulated protein 1 in human T-cell leukemia virus type I-dependent T-cell transformation: implications for adult T-cell leukemia leukemogenesis. Cancer Res. 64, 1287-1292 (2004).
15. Lee, K. N. et al. VDUP1 is required for the development of natural killer cells. Immunity 22, 195-208 (2005).
16. Oka, S. et al. Thioredoxin binding protein-2/thioredoxin-interacting protein is a critical regulator of insulin secretion and peroxisome proliferator-activated receptor function. Endocrinology 150, 1225-1234 (2009).
17. Oka, S. et al. Impaired fatty acid utilization in thioredoxin binding protein-2 (TBP-2)-deficient mice: A unique animal model of Reye syndrome. FASEB J. 20, 121-123 (2006).
18. Hui, T. Y. et al. Mice lacking thioredoxin-interacting protein provide evidence linking cellular redox state to appropriate response to nutritional signals. J. Biol. Chem. 279, 24387-24393 (2004).
19. Parikh, H. et al. TXNIP regulates peripheral glucose metabolism in humans. PLoS Med. 4, e158 (2007).
20. Chutkow, W. A., Patwari, P., Yoshioka, J. & Lee, R. T. Thioredoxin-interacting protein (Txnip) is a critical regulator of hepatic glucose production. J. Biol. Chem. 283, 2397-2406 (2008).
21. Chen, J. et al. Thioredoxin-interacting protein deficiency induces Akt/Bcl-xL signaling and pancreatic beta-cell mass and protects against diabetes. FASEB J. 22, 3581-3594 (2008).
22. Chen, J., Saxena, G., Mungrue, I. N., Lusis, A. J. & Shalev, A. Thioredoxin-interacting protein: a critical link between glucose toxicity and beta-cell apoptosis. Diabetes 57, 938-944 (2008).
23. Hui, S. T. et al. Txnip balances metabolic and growth signaling via PTEN disulfide reduction. Proc. Natl Acad. Sci. USA 105, 3921-3926 (2008).
24. Zhang, C. Y. et al. Uncoupling protein-2 negatively regulates insulin secretion and is a major link between obesity, beta cell dysfunction, and type 2 diabetes. Cell 105, 745-755 (2001).
25. Rosen, E. D. & Spiegelman, B. M. Adipocytes as regulators of energy balance and glucose homeostasis. Nature 444, 847-853 (2006).
26. Sreekumar, R., Halvatsiotis, P., Schimke, J. C. & Nair, K. S. Gene expression profile in skeletal muscle of type 2 diabetes and the effect of insulin treatment. Diabetes 51, 1913-1920 (2002).
27. Tamemoto, H. et al. Insulin resistance and growth retardation in mice lacking insulin receptor substrate-1. Nature 372, 182-186 (1994).
28. Muoio, D. M. & Newgard, C. B. Mechanisms of disease: molecular and metabolic mechanisms of insulin resistance and beta-cell failure in type 2 diabetes. Nat. Rev. Mol. Cell Biol. 9, 193-205 (2008).
29. Hackenbrock, C. R. Ultrastructural bases for metabolically linked mechanical activity in mitochondria. I. Reversible ultrastructural changes with change in metabolic steady state in isolated liver mitochondria. J. Cell Biol. 30, 269-297 (1966).
30. Bonnard, C. et al. Mitochondrial dysfunction results from oxidative stress in the skeletal muscle of diet-induced insulin-resistant mice. J. Clin. Invest. 118, 789-800 (2008).
31. Meglasson, M. D. & Matschinsky, F. M. Pancreatic islet glucose metabolism and regulation of insulin secretion. Diabetes Metab. Rev. 2, 163-214 (1986).
32. MacDonald, M. J. Synergistic potent insulin release by combinations of weak secretagogues in pancreatic islets and INS-1 cells. J. Biol. Chem. 282, 6043-6052 (2007).
33. Oberkofler, H., Klein, K., Felder, T. K., Krempler, F. & Patsch, W. Role of peroxisome proliferator-activated receptor-gamma coactivator-1alpha in the transcriptional regulation of the human uncoupling protein 2 gene in INS-1E cells. Endocrinology 147, 966-976 (2006).
34. Medvedev, A. V. et al. Regulation of the uncoupling protein-2 gene in INS-1 beta-cells by oleic acid. J. Biol. Chem. 277, 42639-42644 (2002).
35. 38 MAPK. Genes Dev. 18, 278-289 (2004).
36. Ahsan, M. K., Nakamura, H., Masutani, H. & Yodoi, J. Thioredoxin and thioredoxin-binding protein-2 in cancer and metabolic syndrome. Free Radic. Biol. Med. 43, 861-868 (2007).
37. Yoshihara, E., Chen, Z., Matsuo, Y., Masutani, H. & Yodoi, J. Thiol redox transitions by thioredoxin and thioredoxin-binding protein-2 in cell signaling. Methods Enzymol. 474, 67-82 (2010).
38. Stoltzman, C. A. et al. Glucose sensing by MondoA:Mlx complexes: a role for hexokinases and direct regulation of thioredoxin-interacting protein expression. Proc. Natl Acad. Sci. USA 105, 6912-6917 (2008).
39. Peterson, C. W., Stoltzman, C. A., Sighinolfi, M. P., Han, K. S. & Ayer, D. E. Glucose controls nuclear accumulation, promoter binding, and transcriptional activity of the MondoA-Mlx heterodimer. Mol. Cell Biol. 30, 2887-2895 (2010).
40. Kaadige, M. R., Looper, R. E., Kamalanaadhan, S. & Ayer, D. E. Glutamine-dependent anapleurosis dictates glucose uptake and cell growth by regulating MondoA transcriptional activity. Proc. Natl Acad. Sci. USA 106, 14878-14883 (2009).
41. Chen, J. L. et al. Lactic Acidosis Triggers Starvation Response with Paradoxical Induction of TXNIP through MondoA. PLoS Genet. 6, e1001093 (2010).
42. Chutkow, W. A. et al. Deletion of the alpha-arrestin protein Txnip in mice promotes adiposity and adipogenesis while preserving insulin sensitivity. Diabetes 59, 1424-1434 (2010).
43. Sesti, G. et al. Defects of the insulin receptor substrate (IRS) system in human metabolic disorders. FASEB J. 15, 2099-2111 (2001).
44. Ferre, P. The biology of peroxisome proliferator-activated receptors: relationship with lipid metabolism and insulin sensitivity. Diabetes 53 (Suppl 1), S43-50 (2004).
45. Shaked, M. et al. Insulin counteracts glucotoxic effects by suppressing thioredoxin-interacting protein production in INS-1E beta cells and in Psammomys obesus pancreatic islets. Diabetologia 52, 636-644 (2009).
46. Masson, E. et al. High beta-cell mass prevents streptozotocin-induced diabetes in thioredoxin-interacting protein-deficient mice. Am. J. Physiol. Endocrinol. Metab. 296, E1251-1261 (2009).
47. Lin, C. H., MacGurn, J. A., Chu, T., Stefan, C. J. & Emr, S. D. Arrestin-related ubiquitin-ligase adaptors regulate endocytosis and protein turnover at the cell surface. Cell 135, 714-725 (2008).
48. Hirasawa, T., Ohara, T. & Makino, S. Genetic typing of the mouse ob mutation by PCR and restriction enzyme analysis. Exp. Anim. 46, 75-78 (1997).
49. Sutton, R., Peters, M., McShane, P., Gray, D. W. & Morris, P. J. Isolation of rat pancreatic islets by ductal injection of collagenase. Transplantation 42, 689-691 (1986).
50. Fujimoto, S. et al. The novel insulinotropic mechanism of pimobendan: Direct enhancement of the exocytotic process of insulin secretory granules by increased Ca2+ sensitivity in beta-cells. Endocrinology 139, 1133-1140 (1998).